Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Noxafil 300 mg gastro-resistant powder and solvent for oral suspension

Active Ingredient:
posaconazole
Company:  
Merck Sharp & Dohme (UK) Limited See contact details
ATC code: 
J02AC04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) User Manual Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

NOXAFIL (posaconazole) new Gastro-Resistant Powder and Solvent for Oral Suspension not interchangeable with existing Oral Suspension including generics

{healthcare_pro_orange} For Healthcare Professionals
The DHPC serves to inform HCPs of the approval of the new formulation and that the existing oral suspension and the new gastro-resistant powder and solvent for oral suspension are not interchangeable. It also provides HCPs with additional instructions to mitigate the risk of medication errors.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Merck Sharp & Dohme (UK) Limited
Company image
Address
120 Moorgate, London, EC2M 6UR, UK
WWW
http://www.msd-uk.com/
Telephone
+44 (0)208 154 8000
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)2081548001